Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06135909 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Nov 1, 2027 to Dec 31, 2027
    • Start date changed from estimate of Dec 1, 2023 to Jan 1, 2020
    • Study title shortened, about 8 words
    • Eligibility criteria shortened, about 1 word
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CHina Registry for the chAracteristics and Management strategieS of patiEnts With Pulmonary Hypertension Using Targeted Therapy (CHASE Study)
Trial Details
NCT Number NCT06135909
Lead Sponsor Chinese Pulmonary Vascular Disease Research Group
Conditions
(from sponsor)		 Pulmonary Hypertension
Related terms Hypertension, Pulmonary
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov